ABO-incompatibility does not influence the outcome after allogeneic hematopoietic stem cell transplantation with dose reduced-intensity conditioning

被引:0
|
作者
Linck, D
Kraut, L
Pohl, H
Kiehl, M
Fauser, A
Basara, N
机构
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
引用
收藏
页码:S147 / S147
页数:1
相关论文
共 50 条
  • [41] 400 cGy TBI with fludarabine for reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation
    Sobecks, R. M.
    Dean, R.
    Rybicki, L. A.
    Chan, J.
    Theil, K. S.
    Macklis, R.
    Andresen, S.
    Kalaycio, M.
    Pohlman, B.
    Ferraro, C.
    Cherni, K.
    Sweetenham, J.
    Copelan, E.
    Bolwell, B. J.
    BONE MARROW TRANSPLANTATION, 2008, 42 (11) : 715 - 722
  • [42] Reduced-intensity conditioning followed by allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia
    Ehninger, G.
    Platzbecker, U.
    Bornhaaeuser, M.
    ANNALS OF HEMATOLOGY, 2006, 85 : 66 - 67
  • [43] Second Malignancies after Allogeneic Stem Cell Transplantation with Reduced-Intensity Conditioning: Is the Incidence Reduced?
    Shimoni, Avichai
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (11) : 1669 - 1670
  • [44] 400 cGy TBI with fludarabine for reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation
    R M Sobecks
    R Dean
    L A Rybicki
    J Chan
    K S Theil
    R Macklis
    S Andresen
    M Kalaycio
    B Pohlman
    C Ferraro
    K Cherni
    J Sweetenham
    E Copelan
    B J Bolwell
    Bone Marrow Transplantation, 2008, 42 : 715 - 722
  • [45] Successful Allogeneic Hematopoietic Stem Cell Transplantation in XIAP Deficiency Using Reduced-Intensity Conditioning
    Chellapandian, Deepak
    Krueger, Joerg
    Schechter, Tal
    Gassas, Adam
    Weitzman, Sheila
    Naqvi, Ahmed
    Ali, Muhammad
    PEDIATRIC BLOOD & CANCER, 2016, 63 (02) : 355 - 357
  • [46] Reduced-intensity allogeneic hematopoietic stem cell transplantation with alemtuzumab conditioning regimens: survival does not plateau until after day 200
    Ho, AYL
    Kenyon, M
    El-Hemaidi, L
    Devereux, S
    Pagliuca, A
    Mufti, GJ
    BLOOD, 2003, 101 (02) : 779 - 780
  • [47] CMV infection and disease after allogeneic stem cell transplantation with reduced-intensity conditioning
    Avetisyan, G.
    Hagglund, H.
    Hassan, Z.
    LeBlanc, K.
    Mattsson, J.
    Ringden, O.
    Winiarski, J.
    Ljungman, P.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S241 - S242
  • [48] Myeloablative after reduced-intensity conditioning allogeneic stem cell transplant: toxicity and outcome?
    Cordonnier, C
    Hamladji, R
    Genitsch, A
    Gratwohl, A
    BONE MARROW TRANSPLANTATION, 2005, 35 : S361 - S362
  • [49] Impact of ABO incompatibility on allogeneic peripheral blood progenitor cell transplantation after reduced intensity conditioning
    Canals, C
    Muñiz-Díaz, E
    Martínez, C
    Martino, R
    Moreno, I
    Ramos, A
    Arilla, M
    Boto, N
    Pastoret, C
    Remacha, A
    Sierra, J
    Madoz, P
    TRANSFUSION, 2004, 44 (11) : 1603 - 1611
  • [50] Immune reconstitution after allogeneic stem cell transplantation with reduced-intensity conditioning regimens
    M Jiménez
    G Ercilla
    C Martínez
    Leukemia, 2007, 21 : 1628 - 1637